Eam Global Investors LLC Cara Therapeutics, Inc. Transaction History

Eam Global Investors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$16.11 - $25.98 $1.03 Million - $1.66 Million	-63,979 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$18.28 - $26.91 $1.17 Million - $1.72 Million	63,979 New	63,979 $1.17 Million
Q4 2018 Feb 13, 2019	SELL	$12.45 - $23.47 $800,485 - $1.51 Million	-64,296 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$17.57 - $23.95 $1.13 Million - $1.54 Million	64,296 New	64,296 $1.54 Million

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.